Resolys Bio, Inc. — Form D/A
Resolys Bio, Inc. of DELANSON, NY, a company, filed a Form D amendment with the SEC on 2017-09-25. The offering totals $6.0M, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-09-25
- Form: D/A
- Accession: 0001193805-17-002059
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $200K
- Remaining: $5.8M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2017-09-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-263521
Issuer
- Name: Resolys Bio, Inc.
- CIK: 0001674941
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 545 WESTFALL ROAD, DELANSON, NY, 12053
- Phone: 518-872-1144
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Jeffrey A Eckmann | Director | Delanson, NY |
| Thomas A Hatch | Director | Delanson, NY |
| Richard A Sandberg | Director | Shelton, CT |
| James A Tobin | Director | Delanson, NY |
| John McMichael | Executive Officer | Delanson, NY |
| Richard A Sandberg | Executive Officer | Shelton, CT |
| Stephen Hill | Director | Lake Forest, IL |
| Chris Garabedian | Director | San Francisco, CA |
| Chris Garabedian | Executive Officer | San Francisco, CA |
| Damian Marron | Director | Valbonne, I0 |
| Thomas Hatch | Director | Farmington, UT |
| McKay Belk | Director | Denver, CO |
| Richard Sandberg | Executive Officer | New Canaan, CT |
| John McMichael | Director | Delanson, NY |
| Thomas C Hatch | Director | Delanson, NY |
Other filings by this issuer (3)
More